|Awarded On||August 21, 2019|
|Title||Business-Driven Accelerator for Cancer Therapeutics (BDACT)|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Texas Medical Center Foundation|
|Principal Investigator/Program Director||Tom Luby|
|Cancer Sites||All Sites|
Successfully delivering new cancer therapeutics discoveries to patients is a long, difficult, and expensive process. To do this successfully, cancer researchers most often must develop a small company or partner with an established pharmaceutical company. For many Texas cancer researchers, this is a major hurdle. The difficulty Texas researchers experience in successfully moving their cancer discoveries to patients is evidenced by the small number of technology commercialization grants awarded to Texas compared to other states. There is a lack of biotech entrepreneurship training and comprehensive drug development programs in Texas. BDACT will address these deficits and provide Texas researc...